Jeffrey Scott Riley - Net Worth and Insider Trading
Jeffrey Scott Riley Net Worth
The estimated net worth of Jeffrey Scott Riley is at least $62,251 dollars as of 2024-11-13. Jeffrey Scott Riley is the Director of Gain Therapeutics Inc and owns about 30,000 shares of Gain Therapeutics Inc (GANX) stock worth over $62,250. Jeffrey Scott Riley is also the CEO and President of Theriva Biologics Inc and owns about 1 shares of Theriva Biologics Inc (TOVX) stock worth over $1. Details can be seen in Jeffrey Scott Riley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Scott Riley has not made any transactions after 2024-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Scott Riley
Jeffrey Scott Riley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Scott Riley owns 2 companies in total, including Theriva Biologics Inc (TOVX) , and Gain Therapeutics Inc (GANX) .
Click here to see the complete history of Jeffrey Scott Riley’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Scott Riley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TOVX | Theriva Biologics Inc | 2013-01-07 | director |
| GANX | Gain Therapeutics Inc | 2024-03-28 | director |
Jeffrey Scott Riley Latest Holdings Summary
Jeffrey Scott Riley currently owns a total of 2 stocks. Among these stocks, Jeffrey Scott Riley owns 30,000 shares of Gain Therapeutics Inc (GANX) as of March 28, 2024, with a value of $62,250 and a weighting of 100%. Jeffrey Scott Riley also owns 1 shares of Theriva Biologics Inc (TOVX) as of January 7, 2013, with a value of $1 and a weighting of 0%.
Latest Holdings of Jeffrey Scott Riley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GANX | Gain Therapeutics Inc | 2024-03-28 | 30,000 | 2.08 | 62,250 |
| TOVX | Theriva Biologics Inc | 2013-01-07 | 1 | 1.43 | 1 |
Holding Weightings of Jeffrey Scott Riley
Jeffrey Scott Riley Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Scott Riley has made a total of 1 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gain Therapeutics Inc is the acquisition of 30,000 shares on March 28, 2024, which cost Jeffrey Scott Riley around $115,800.
According to the SEC Form 4 filings, Jeffrey Scott Riley has made a total of 0 transactions in Theriva Biologics Inc (TOVX) over the past 5 years. The most-recent trade in Theriva Biologics Inc is the acquisition of 0 shares on January 7, 2013, which cost Jeffrey Scott Riley around $493.
Insider Trading History of Jeffrey Scott Riley
- 1
Jeffrey Scott Riley Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Scott Riley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Scott Riley is -21.01%. GuruFocus also compares Jeffrey Scott Riley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Scott Riley within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Scott Riley's insider trading performs compared to the benchmark.
Performance of Jeffrey Scott Riley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.08 | | | | | |
| Relative Return to S&P 500(%) | 1.16 | | | | | |
Jeffrey Scott Riley Ownership Network
Ownership Network List of Jeffrey Scott Riley
Ownership Network Relation of Jeffrey Scott Riley
Jeffrey Scott Riley Owned Company Details
What does Theriva Biologics Inc do?
Who are the key executives at Theriva Biologics Inc?
Jeffrey Scott Riley is the director of Theriva Biologics Inc. Other key executives at Theriva Biologics Inc include director & CEO and CFO Steven A Shallcross , Chief Operating Officer Francis Tufaro , and 10 percent owner Randal J Kirk .
Theriva Biologics Inc (TOVX) Insider Trades Summary
Over the past 18 months, Jeffrey Scott Riley made no insider transaction in Theriva Biologics Inc (TOVX). Other recent insider transactions involving Theriva Biologics Inc (TOVX) include a net purchase of 40,000 shares made by Steven A Shallcross ,
In summary, during the past 3 months, insiders sold 0 shares of Theriva Biologics Inc (TOVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theriva Biologics Inc (TOVX) were sold and 1,600 shares were bought by its insiders, resulting in a net purchase of 1,600 shares.
Theriva Biologics Inc (TOVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theriva Biologics Inc Insider Transactions
Jeffrey Scott Riley Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Scott Riley. You might contact Jeffrey Scott Riley via mailing address: C/o Adeona Pharmaceuticals, Inc, 3930 Varsity Drive, Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
